Similar articles for PMID: 30410066

Year	Number of Results
1985	1
1989	1
1993	1
1994	1
1999	2
2002	3
2003	1
2004	2
2005	4
2007	3
2008	1
2012	2
2013	3
2014	5
2015	10
2016	16
2017	12
2018	24
2019	6
2020	13
2021	15
2022	3
2023	2
2024	0

1

Evolving changes in M-protein and hemoglobin as predictors for progression of smoldering multiple myeloma.

Atrash S, Robinson M, Slaughter D, Aneralla A, Brown T, Robinson J, Ndiaye A, Sprouse C, Zhang Q, Symanowski JT, Friend R, Voorhees PM, Usmani SZ, Bhutani M. Atrash S, et al. Blood Cancer J. 2018 Nov 8;8(11):107. doi: 10.1038/s41408-018-0144-x. Blood Cancer J. 2018. PMID: 30410066 Free PMC article. No abstract available.

2

The pattern of the M-protein in smoldering myeloma over the time: an evolving risk factor.

Fernández de Larrea C, Isola I, Pereira A, Cibeira MT, Bladé J, Rosiñol L. Fernández de Larrea C, et al. Leukemia. 2018 Sep;32(9):2082-2094. doi: 10.1038/s41375-018-0156-3. Epub 2018 May 23. Leukemia. 2018. PMID: 29795240 No abstract available.

3

Response to 'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression'.

Lakshman A, Ravi P, Rajkumar SV, Kumar SK. Lakshman A, et al. Leukemia. 2018 Sep;32(9):2083-2085. doi: 10.1038/s41375-018-0155-4. Epub 2018 May 25. Leukemia. 2018. PMID: 29802327 No abstract available.

4

Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling.

Wu V, Moshier E, Leng S, Barlogie B, Cho HJ, Jagannath S, Madduri D, Mazumdar M, Parekh S, Chari A. Wu V, et al. Blood Adv. 2018 Jun 26;2(12):1470-1479. doi: 10.1182/bloodadvances.2018016998. Blood Adv. 2018. PMID: 29945937 Free PMC article.

5

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

Lakshman A, Rajkumar SV, Buadi FK, Binder M, Gertz MA, Lacy MQ, Dispenzieri A, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Leung N, Go RS, Lin Y, Kourelis TV, Warsame R, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK. Lakshman A, et al. Blood Cancer J. 2018 Jun 12;8(6):59. doi: 10.1038/s41408-018-0077-4. Blood Cancer J. 2018. PMID: 29895887 Free PMC article.

6

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression.

Fernández de Larrea C, Isola I, Pereira A, Cibeira MT, Magnano L, Tovar N, Rodríguez-Lobato LG, Calvo X, Aróstegui JI, Díaz T, Lozano E, Rozman M, Yagüe J, Bladé J, Rosiñol L. Fernández de Larrea C, et al. Leukemia. 2018 Jun;32(6):1427-1434. doi: 10.1038/s41375-018-0013-4. Epub 2018 Feb 2. Leukemia. 2018. PMID: 29463830

7

Baseline serum B-cell maturation antigen levels predict time to disease progression for patients with smoldering multiple myeloma.

Bujarski S, Goldwater MS, Regidor BS, Jew S, Daniely D, Swift RA, Eades BM, Emamy-Sadr M, Souther E, Li M, Wang C, Xu N, Chen H, Spektor TM, Berenson JR. Bujarski S, et al. Eur J Haematol. 2021 Sep;107(3):318-323. doi: 10.1111/ejh.13666. Epub 2021 Jun 14. Eur J Haematol. 2021. PMID: 33993536

8

Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression.

Gran C, Luong V, Bruchfeld JB, Liwing J, Afram G, Lund J, Usmani S, Alici E, Nahi H. Gran C, et al. Am J Hematol. 2021 Mar 1;96(3):E63-E65. doi: 10.1002/ajh.26062. Epub 2020 Dec 19. Am J Hematol. 2021. PMID: 33264449 Free PMC article. No abstract available.

9

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice.

Cocito F, Mangiacavalli S, Ferretti VV, Cartia CS, Ganzetti M, Benveuti P, Pompa A, Catalano M, Fugazza E, Landini B, Arcaini L, Corso A. Cocito F, et al. Leuk Lymphoma. 2019 Dec;60(12):2968-2974. doi: 10.1080/10428194.2019.1620948. Epub 2019 Jun 6. Leuk Lymphoma. 2019. PMID: 31169049

10

Prevalence, incidence and survival of smoldering multiple myeloma in the United States.

Ravindran A, Bartley AC, Holton SJ, Gonsalves WI, Kapoor P, Siddiqui MA, Hashmi SK, Marshall AL, Ashrani AA, Dispenzieri A, Kyle RA, Rajkumar SV, Go RS. Ravindran A, et al. Blood Cancer J. 2016 Oct 21;6(10):e486. doi: 10.1038/bcj.2016.100. Blood Cancer J. 2016. PMID: 27768092 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

116 results

Results by year